Background. The development of new bifunctional chelating agents for the labeling of monoclonal antibodies with radiometals is a desirable goal in the area of radioimmunodetection and radioimmunotherapy of cancer. The authors have developed a new N,S-ligand, N-(S-acetylmercaptoacetyl) (p-NCS)phenyla
Direct 99mTc labeling of monoclonal antibodies: evaluation of reducing agents and HPLC analysis
✍ Scribed by Ning Liu; Jiannan Jin; Shangwu Mo; Hengliu Chen; Yanping Yu; Bingxun Xu; Qi Chen
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- French
- Weight
- 416 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Peptides are known as receptor‐specific molecules that play an important role not only in diagnosis and therapy of neoplastic diseases, but also in the pathogenesis of other diseases. In an effort to develop a peptide‐based radiopharmaceutical for scintigraphic studies, a small peptide
## Abstract Mono‐[^123^I]iodohypericin and mono‐[^123^I]iodohypericin monocarboxylic acid are iodine‐123‐labeled hypericin derivatives which have shown great promise in preclinical studies as necrosis avid imaging agents in animal models of infarction. In view of the more attractive properties of a
## Abstract Thioflavin‐T is a fluorescent dye for __in vitro__ detection of fibrillar amyloid β, a protein found in the brain of patients suffering from Alzheimer's disease. We synthesized and biologically evaluated two uncharged ^99m^Tc‐labeled derivatives of thioflavin‐T. The precursors for label
## Abstract A novel and efficient method for preparing ^99m^Tc‐complexes of radiopharmaceuticals has been developed by reacting [^99m^Tc]pertechnetate with a ligand in the presence of borohydride exchange resin (BER) as a reducing agent. The latter is stable over a wide range of pH (2–11) and thus